Article
Current and emerging treatment options for Wiskott-Aldrich syndrome.
Expert review of clinical immunology - 1 Jan 2015
Worth Austen J J, Thrasher Adrian J
Abstract excerpt
Wiskott-Aldrich syndrome is a life-threatening primary immunodeficiency associated with a bleeding tendency, eczema and a high incidence of autoimmunity and malignancy. Stem cell transplantation offers the opportunity of cure for all these complications, and over the past 35 years there has been a remarkable improvement in survival following this treatment. Here, we review advances in management of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
